Ketorolac Tromethamine Injec · #11 of 35 active shortages by FDA posting duration
FDA lists Ketorolac Tromethamine Injec as Active Shortage (Gland Pharma Limited).
Availability on file: Available
Ketorolac Tromethamine Injection: Active Shortage
Available 25 shortage presentations are tracked for this drug. Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Ketorolac Tromethamine Injection
- Manufacturer
- Gland Pharma Limited
- Dosage Form
- Injection
- Presentation
- Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 70860-700-02)
- Package NDC
- 70860-700-02
Status & Timeline
- Status
- Active Shortage
- Availability
- Available
- First Reported
- Mar 23, 2018
- Last Updated
- Sep 29, 2025
- Therapeutic Category
- Analgesia/Addiction
Row fields from the FDA Drug Shortages database via openFDA.
Shortage Reason
Athenex is not active, supplying through Sagent NDC 25021-700-01
Full Drug Profile
ketorolac
Side effects, interactions, warnings & more
Nearby, Other Ketorolac Shortage Records
Ketorolac Tromethamine Injection
Gland Pharma Limited
Injection
Ketorolac Tromethamine Injection
Gland Pharma Limited
Injection
Ketorolac Tromethamine Injection
Gland Pharma Limited
Injection
Ketorolac Tromethamine Injection
Gland Pharma Limited
Injection
Ketorolac Tromethamine Injection
Alembic Pharmaceuticals
Injection
Ketorolac Tromethamine Injection
Alembic Pharmaceuticals
Injection
FDA reason on file: Athenex is not active, supplying through Sagent NDC 25021-700-01. General shortage guidance lives on the tracker hub.